This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
ad-tech: Archive
Down 10.2% in 4 Weeks, Here's Why Fidelity National (FIS) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Fidelity National (FIS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
FISPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing rsi saas self-driving-cars smart-health social-media stock-price-movement vaccines
Down 12.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Global Payments (GPN)
by Zacks Equity Research
Global Payments (GPN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
GPNPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing rsi saas self-driving-cars smart-health social-media stock-price-movement vaccines
New to Investing? This 1 Basic Materials Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
CEPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-estimates fin-tech furniture-retailers gene-editing gene-therapy growth-investing home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-consensus-estimate zacks-rank
Why Capital One (COF) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
COFPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked undervalued-stocks vaccines value-stocks
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NVSPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CCPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why Agco (AGCO) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AGCOPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ACGLNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media top-ranked vaccines
The Zacks Rank Explained: How to Find Strong Buy Construction Stocks
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
KBHPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank
This Top Retail and Wholesale Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
LADPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank
This Top Retail and Wholesale Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
ORLYNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank
How to Find Strong Buy Construction Stocks Using the Zacks Rank
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
AYIPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank
This Top Consumer Discretionary Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
CROXPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy growth-investing high-growth home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines zacks-rank
Piper Sandler Companies (PIPR) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Piper Sandler Companies (PIPR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
PIPRPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-performance ride-hailing saas self-driving-cars smart-health social-media stock-price-change stock-price-movement vaccines
Recent Price Trend in Marubeni Corp. (MARUY) is Your Friend, Here's Why
by Zacks Equity Research
Marubeni Corp. (MARUY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
MARUYPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-performance ride-hailing saas self-driving-cars smart-health social-media stock-price-change stock-price-movement vaccines
How Investors Can Grab Better Returns for Retail and Wholesale Using the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
HIBBPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-esp earnings-expectations earnings-outlook fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Computer and Technology
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
AVTPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-esp earnings-expectations earnings-outlook fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Spirit of Texas (STXB) Is a Great Choice for "Trend" Investors, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Spirit of Texas (STXB) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
STXBPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-performance ride-hailing saas self-driving-cars smart-health social-media stock-price-change stock-price-movement vaccines
Erste Group Bank AG (EBKDY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Erste Group Bank AG (EBKDY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
EBKDYNegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-performance ride-hailing saas self-driving-cars smart-health social-media stock-price-change stock-price-movement vaccines
Fast-paced Momentum Stock AdvanSix (ASIX) Is Still Trading at a Bargain
by Zacks Equity Research
AdvanSix (ASIX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
ASIXPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Why Fast-paced Mover Wesco International (WCC) Is a Great Choice for Value Investors
by Zacks Equity Research
Wesco International (WCC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
WCCPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna momentum-investor momentum-stocks oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
How to Boost Your Portfolio with Top Utilities Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
BCENegative Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-esp earnings-expectations earnings-outlook fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
How Investors Can Grab Better Returns for Construction Using the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
MTZPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-esp earnings-expectations earnings-outlook fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
How Investors Can Grab Better Returns for Computer and Technology Using the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
CMBMPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing earnings-esp earnings-expectations earnings-outlook fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments ride-hailing saas self-driving-cars smart-health social-media vaccines
Northfield (NFBK) Is a Great Choice for "Trend" Investors, Here's Why
by Zacks Equity Research
Northfield (NFBK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
NFBKPositive Net Change
ad-tech automation autonomous-vehicles batteries cell-therapy creator-economy dna-sequencing fin-tech furniture-retailers gene-editing gene-therapy home-buying-apps immuno-therapy medical-devices messenger-rna oncology-screening payments price-performance ride-hailing saas self-driving-cars smart-health social-media stock-price-change stock-price-movement vaccines